
News|Articles|February 13, 2019
- Drug Topics March 2019
- Volume 163
- Issue 3
Xofluza for Acute Uncomplicated Influenza
Author(s)Drew Boxler
Advertisement
Xofluza (baloxavir marboxil, Genetech)
Indications: acute uncomplicated influenza in patients 12+, <48hr symptomatic
Dosage:
- 40-80kg body = 40 mg
- 80kg+ = 80 mg
Contraindications: history of hypersensitivity to baloxair marboxil or any of its ingredients
Articles in this issue
over 6 years ago
Coping with Patient Deathover 6 years ago
Opinion: Why Change Is Like a Hemorrhoidectomyover 6 years ago
Pharmacists Want More Time with Patientsover 6 years ago
The Pros and Cons of Switching to a Health Systemover 6 years ago
Early Planning is Key to Retirement and Successionover 6 years ago
Dietary Supplements Need Evidence and Evaluationover 6 years ago
Reconnect to Reinvigorateover 6 years ago
Pharmacy Education for the 21st Centuryover 6 years ago
How to Achieve Balance in Work and in Lifeover 6 years ago
Case Studies in StabilityNewsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: TrumpRx Could Change the Way Pharmacies, PBMs Do Business
2
FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths
3
Trump Administration Looking to Bypass PBMs Through Online DTC Pharmacy
4
New Research Highlights Dietary Interventions to Potentially Manage Asthma
5





































































































































